Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis.

Bibliographic Details
Title: Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis.
Authors: Yu, Xianzhe (AUTHOR), Zhu, Lingling (AUTHOR), Liu, Jiewei (AUTHOR), Xie, Ming (AUTHOR), Chen, Jiang (AUTHOR), Li, Jianguo (AUTHOR)
Source: OncoTargets & Therapy. Nov2020, Vol. 13, p11645-11658. 14p.
Subject Terms: *IMMUNOTHERAPY, *LIVER metastasis, *METASTASIS, *LIVER cancer, *COLORECTAL cancer, *IMMUNE checkpoint inhibitors
Abstract: Colorectal cancer (CRC) is the third most common malignant tumor in the world and the second leading cause of cancer-related deaths, with the liver as the most common site of distant metastasis. The prognosis of CRC with liver metastasis is poor, and most patients cannot undergo surgery. In addition, conventional antitumor approaches such as chemotherapy, radiotherapy, targeted therapy, and surgery result in unsatisfactory outcomes. In recent years, immunotherapy has shown good prospects in the treatment of assorted tumors by enhancing the host's antitumor immune function, and it may become a new effective treatment for liver metastasis of CRC. However, challenges remain in applying immunotherapy to CRC with liver metastasis. This review examines how the microenvironment and immunosuppressive landscape of the liver favor tumor progression. It also highlights the latest research advances in immunotherapy for colorectal liver metastasis and identifies immunotherapy as a treatment regimen with a promising future in clinical applications. [ABSTRACT FROM AUTHOR]
Copyright of OncoTargets & Therapy is the property of Dove Medical Press Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
Full text is not displayed to guests.
More Details
ISSN:11786930
DOI:10.2147/OTT.S271955
Published in:OncoTargets & Therapy
Language:English